(1 - 32 von 100
)
MorphoSys AG Announcements | MorphoSys AG Investegatewww.investegate.co.uk › gnw › morphosys-announ...
www.investegate.co.uk
· ... Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG. "In total, our collaboration with Novartis has resulted in eight clinical antibodies to ...
(PZ) MorphoSys AG Reports Financial Results for Fiscal Year 2005
www.chron.com
... investor base -- Appointment of Dr. Marlies Sproll as Chief Scientific Officer ... Under International Financial Reporting Standards (IFRS), revenues for the ... collaborations with Bayer (USA), Boehringer Ingelheim (Germany), ...
BRIEF-Morphosys names Enzelberger as new chief scientific officer |...
www.reuters.com
* Says Dr. Markus Enzelberger appointed chief scientific officer
MorphoSys Appoints Dr. Marlies Sproll as Chief Scientific Officer ...www.globenewswire.com › › MorphoS...
www.globenewswire.com
Marlies Sproll (47) as Chief Scientific Officer and a member of its Management Board. The appointment will take effect on November 1, Dr. Sproll will lead ...
sortiert nach Relevanz / Datum